Metabolic Changes of Thalamus Assessed by H-MRS Spectroscopy in Patients of Cervical Spondylotic Myelopathy Following Decompression Surgery

Overview

Journal Front Neurol

Date 2025 Jan 23

PMID 39845933

Authors

Jiangqin Zheng

Yujin Zhang

Baogen Zhao

Ning Wang

Ting Gao

Li Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: To assess the changes of thalamic metabolites before and after surgery in patients with Cervical Spondylotic Myelopathy (CSM) using Hydrogen Proton Magnetic Resonance Spectroscopy (H-MRS) and to investigate its association with improvement in neurological function.

Methods: Forty-eight CSM patients who underwent cervical decompression surgery from December 2022 to June 2023 were included, and 33 healthy volunteers were recruited. All subjects underwent bilateral thalamic H-MRS scans before the surgical procedure, and subsequently again 6 months later. Neurological function was assessed pre-operatively and post-operatively (6 months) in all patients with CSM using the modified Japanese Orthopedic Association (mJOA). The changes of mJOA (ΔmJOA = postoperative mJOA-preoperative mJOA) were employed as an indicator of neurological improvement. The pre- and postoperative metabolic ratio of -acetylaspartate/creatine (NAA/Cr), choline/creatine (Cho/Cr), myo-inositol/creatine (mI/Cr), glutamate and glutamine complex/creatine (Glx/Cr) were statistically compared in CSM patients and healthy controls (HCs). A correlation analysis was conducted to determine the relationship between alterations in pre- and postoperative metabolite ratios (ΔNAA/Cr, ΔCho/Cr, ΔmI/Cr, ΔGlx/Cr) and ΔmJOA.

Results: Compared to the HCs, patients with CSM showed significantly lower pre- and post-operative NAA/Cr ( = -4.235,  < 0.001;  = -3.184,  = 0.001), Cho/Cr ( = -5.050,  < 0.001; ( = -2.624,  = 0.007) and mI/Cr ( = -3.739,  = 0.001;  = -2.014,  = 0.044). There was no difference in Glx/Cr between patients in patients with CSM, either preoperatively or postoperatively, compared to HCs. Post-operative NAA/Cr (  = -2.285,  = 0.041) and mI/Cr ( = -2.925,  = 0.021) were increased in CSM patients compared to pre-operative NAA/Cr and mI/Cr. In CSM patients, ΔmI/Cr correlated significantly with ΔmJOA ( = 0.507,  < 0.001).

Conclusion: The preliminary findings indicate that metabolites in the thalamus of CSM patients exhibit changes following surgery. Additionally, it has been demonstrated that elevated postoperative mI correlates with improvements in neurological function.

References

Aleksanderek I, McGregor S, Stevens T, Goncalves S, Bartha R, Duggal N . Cervical Spondylotic Myelopathy: Metabolite Changes in the Primary Motor Cortex after Surgery. Radiology. 2016; 282(3):817-825. DOI: 10.1148/radiol.2016152083. View

Ashwal S, Holshouser B, Tong K, Serna T, Osterdock R, Gross M . Proton spectroscopy detected myoinositol in children with traumatic brain injury. Pediatr Res. 2004; 56(4):630-8. DOI: 10.1203/01.PDR.0000139928.60530.7D. View

Kuang C, Zha Y . Abnormal intrinsic functional activity in patients with cervical spondylotic myelopathy: a resting-state fMRI study. Neuropsychiatr Dis Treat. 2019; 15:2371-2383. PMC: 6708884. DOI: 10.2147/NDT.S209952. View

Wang L, Yu B, Li Q, Qi F, Guo Q . Sensorimotor cortex atrophy in patients with cervical spondylotic myelopathy. Neuroreport. 2018; 29(10):826-832. PMC: 5999381. DOI: 10.1097/WNR.0000000000001039. View

Moxon-Emre I, Croarkin P, Daskalakis Z, Blumberger D, Lyon R, Tani H . NAA/Glu Ratio Associated with Suicidal Ideation in Pilot Sample of Autistic Youth and Young Adults. Brain Sci. 2022; 12(6). PMC: 9220790. DOI: 10.3390/brainsci12060785. View

Grabher P, Mohammadi S, Trachsler A, Friedl S, David G, Sutter R . Voxel-based analysis of grey and white matter degeneration in cervical spondylotic myelopathy. Sci Rep. 2016; 6:24636. PMC: 4837346. DOI: 10.1038/srep24636. View

Paquette A, Carbone B, Vogel S, Israel E, Maria S, Patil N . The human milk component -inositol promotes neuronal connectivity. Proc Natl Acad Sci U S A. 2023; 120(30):e2221413120. PMC: 10374161. DOI: 10.1073/pnas.2221413120. View

Tsitsopoulos P, Holmstrom U, Blennow K, Zetterberg H, Marklund N . Cerebrospinal fluid biomarkers of glial and axonal injury in cervical spondylotic myelopathy. J Neurosurg Spine. 2021; 34(4):632-641. DOI: 10.3171/2020.8.SPINE20965. View

Ellingson B, Salamon N, Holly L . Advances in MR imaging for cervical spondylotic myelopathy. Eur Spine J. 2013; 24 Suppl 2:197-208. PMC: 4879123. DOI: 10.1007/s00586-013-2915-1. View

10.

Choy W, Chen L, De Oliveira C, Verhagen A, Damodaran O, Anderson D . Gait assessment tools for degenerative cervical myelopathy: a systematic review. J Spine Surg. 2022; 8(1):149-162. PMC: 8990400. DOI: 10.21037/jss-21-109. View

11.

Sun L, Li M, Li Y . Predictors for Surgical Outcome of Laminoplasty for Cervical Spondylotic Myelopathy. World Neurosurg. 2016; 94:89-96. DOI: 10.1016/j.wneu.2016.06.092. View

12.

Lee J, Satkunendrarajah K, Fehlings M . Development and characterization of a novel rat model of cervical spondylotic myelopathy: the impact of chronic cord compression on clinical, neuroanatomical, and neurophysiological outcomes. J Neurotrauma. 2011; 29(5):1012-27. DOI: 10.1089/neu.2010.1709. View

13.

Benzel E, Lancon J, Kesterson L, Hadden T . Cervical laminectomy and dentate ligament section for cervical spondylotic myelopathy. J Spinal Disord. 1991; 4(3):286-95. DOI: 10.1097/00002517-199109000-00005. View

14.

Aleksanderek I, Stevens T, Goncalves S, Bartha R, Duggal N . Metabolite and functional profile of patients with cervical spondylotic myelopathy. J Neurosurg Spine. 2017; 26(5):547-553. DOI: 10.3171/2016.9.SPINE151507. View

15.

Wen C, Cui J, Mak K, Luk K, Hu Y . Diffusion tensor imaging of somatosensory tract in cervical spondylotic myelopathy and its link with electrophysiological evaluation. Spine J. 2013; 14(8):1493-500. DOI: 10.1016/j.spinee.2013.08.052. View

16.

Ryan K, Goncalves S, Bartha R, Duggal N . Motor network recovery in patients with chronic spinal cord compression: a longitudinal study following decompression surgery. J Neurosurg Spine. 2018; 28(4):379-388. DOI: 10.3171/2017.7.SPINE1768. View

17.

Gaudet A, Fonken L . Glial Cells Shape Pathology and Repair After Spinal Cord Injury. Neurotherapeutics. 2018; 15(3):554-577. PMC: 6095774. DOI: 10.1007/s13311-018-0630-7. View

18.

Badhiwala J, Wilson J . The Natural History of Degenerative Cervical Myelopathy. Neurosurg Clin N Am. 2017; 29(1):21-32. DOI: 10.1016/j.nec.2017.09.002. View

19.

Fernando K, McLean M, Chard D, MacManus D, Dalton C, Miszkiel K . Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain. 2004; 127(Pt 6):1361-9. DOI: 10.1093/brain/awh153. View

20.

Erschbamer M, Oberg J, Westman E, Sitnikov R, Olson L, Spenger C . 1H-MRS in spinal cord injury: acute and chronic metabolite alterations in rat brain and lumbar spinal cord. Eur J Neurosci. 2011; 33(4):678-88. PMC: 3072523. DOI: 10.1111/j.1460-9568.2010.07562.x. View